Physician profile
Mark Gdowski
NPI 1831453505
$54,029.52
in general payments reported to CMS, 2019-2025
46 companies · $4,007 in 2025
The $4,007 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,379 · 2020: $32K · 2021: $5,166 · 2022: $3,070 · 2023: $3,511 · 2024: $3,500 · 2025: $4,007.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,019.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $21,480.29 | 2019-2020 | |
| Abbott Laboratories | $13,588.97 | 2019-2025 | Mitraclip, Amplatzer, Triclip |
| Edwards Lifesciences Corporation | $5,246.26 | 2021-2025 | Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $2,329.68 | 2019-2025 | Watchman Access System, Synergy, Rotablator Rotational Atherectomy System Console Kit |
| Abiomed | $1,670.22 | 2019-2025 | Impella |
| Medtronic, INC. | $1,436.85 | 2021-2025 | Ffrangio, Micra, Azure Xt Dr Mri Surescan |
| Philips North America LLC | $1,281.08 | 2019-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Ck4) Mcot, (Br0) Coronary Atherectomy |
| Shockwave Medical, INC | $970.18 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $763.32 | 2022-2025 | |
| Amgen INC. | $710.38 | 2021-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $468.62 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $449.30 | 2022-2025 | |
| Penumbra, INC. | $376.69 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $303.93 | 2019-2025 | Farxiga, Wainua |
| Heartflow, INC. | $301.38 | 2024-2025 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $274.44 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Cardiovascular Systems INC. | $215.47 | 2019-2023 | Diamondback Coronary |
| Merck Sharp & Dohme LLC | $189.34 | 2021-2025 | Verquvo |
| Zoll Circulation INC | $155.42 | 2020-2025 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Biosense Webster, INC. | $145.49 | 2021-2024 | Carto 3 |
| Biotronik INC. | $136.36 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $115.01 | 2024-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $112.97 | 2022-2023 | Xarelto |
| Esperion Therapeutics, INC. | $104.44 | 2022-2025 | Nexletol |
| Cvrx, INC. | $103.49 | 2023 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $91.88 | 2024 | |
| Kestra Medical Technology Services, INC. | $90.17 | 2025 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $87.73 | 2024-2025 | Evkeeza, Praluent |
| Daiichi Sankyo INC. | $87.43 | 2022-2023 | Injectafer |
| Kiniksa Pharmaceuticals, Ltd. | $82.53 | 2023 | Arcalyst |
| Impulse Dynamics (USA) INC. | $78.78 | 2022-2023 | Optimizer |
| Kiniksa Pharmaceuticals International, Plc | $71.00 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.91 | 2021-2025 | Jardiance |
| Bridgebio Pharma, INC. | $52.97 | 2025 | Attruby |
| Amarin Pharma, INC. | $48.99 | 2022 | |
| Azurity Pharmaceuticals, INC. | $44.00 | 2024-2025 | Edarbi |
| Teleflex LLC | $43.89 | 2021-2024 | Supercross |
| Terumo Medical Corporation | $42.62 | 2023-2025 | Tr Band, Angio-Seal, Azur Cx Detachable |
| Lilly USA, LLC | $41.04 | 2025 | Zepbound, Mounjaro |
| Irhythm Technologies, INC. | $39.58 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Lexicon Pharmaceuticals, INC. | $35.25 | 2023-2024 | Inpefa |
| Stemline Therapeutics INC. | $20.59 | 2024 | Orserdu |
| Vital Connect, INC | $20.10 | 2024 | Vitalpatch Rtm |
| Portola Pharmaceuticals, LLC | $19.56 | 2020 | |
| Scpharmaceuticals INC. | $18.56 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.36 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Gdowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.